Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
-
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the...
-
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Cartilage Repair Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
-
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors),...
-
Wilmington, Delaware, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Global Cartilage Repair and Cartilage Regeneration Market value is estimated at US$ 1.4 billion in 2023 and is expected to grow at a...
-
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Cartilage Repair / Cartilage Regeneration - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global...
-
Dublin, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The "Knee Cartilage Repair - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings...
-
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
-
WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ‒ Histogenics and FDA Continue Discussions on NeoCart® Phase 3 Data and Potential BLA Submission ‒‒ October 2018 Financing Expected to...
-
WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...